Target intelligence / Profile preview

U6 small nuclear RNA 1239, pseudogene (RNU6-1239P)

Target
RNU6-1239P
Molecular classification
Other, Non-coding RNA pseudogene, Small nuclear RNA (snRNA)-derived pseudogene
01

Overview

U6 small nuclear RNA 1239, pseudogene (RNU6-1239P) is a processed pseudogene related to the highly conserved U6 small nuclear RNA gene, a core component of the spliceosome critical for pre-mRNA splicing in eukaryotes[1][2][5]. U6 snRNA pseudogenes, including RNU6-1239P, are non-coding genomic elements formed primarily through retrotransposition mechanisms such as LINE-1-mediated reverse transcription[2][5]. Unlike functional U6 snRNA genes, these pseudogenes typically do not encode active RNA products and do not contribute directly to canonical spliceosomal function[2]. However, transcripts from some pseudogenes (including snRNA pseudogenes in general) have been shown in other contexts to participate in gene regulation at the RNA level, for example as antisense RNAs, small interfering RNAs, or as competing endogenous RNAs, though most individual U6 pseudogenes have no well-defined biological role[4]. RNU6-1239P is not recognized as a therapeutic target or biomarker, has no known direct disease association, and no drugs are known to interact with it.

Other names
RNU6-1239PRNA, U6 small nuclear 1239, pseudogene
02

Biological functions

Other (U6 snRNA pseudogenes generally do not possess canonical biological functions, but pseudogene transcripts can theoretically act as competing endogenous RNAs, small interfering RNAs, or regulatory RNAs[4])
03

Disease associations

Other (No known direct disease association for individual U6 snRNA pseudogenes such as RNU6-1239P; alterations in pseudogene activity in general may contribute to gene expression changes in disease[4])

Beyond the preview

Go deeper on U6 small nuclear RNA 1239, pseudogene (RNU6-1239P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U6 small nuclear RNA 1239, pseudogene (RNU6-1239P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call